Glenmede Trust’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $61.1M | Buy |
538,822
+15,531
| +3% | +$1.54M | 0.27% | 79 |
|
|
2026
Q1 | $49.3M | Sell |
523,291
-25,715
| -5% | -$2.57M | 0.24% | 79 |
|
|
2025
Q4 | $54.2M | Buy |
+549,006
| New | +$53.1M | 0.26% | 81 |
|
|
2025
Q1 | $38.1M | Sell |
629,926
-7,044
| -1% | -$491K | 0.2% | 106 |
|
|
2024
Q4 | $44M | Sell |
636,970
-60,055
| -9% | -$4.28M | 0.22% | 97 |
|
|
2024
Q3 | $46.1M | Sell |
697,025
-156,962
| -18% | -$10M | 0.22% | 97 |
|
|
2024
Q2 | $51.8M | Buy |
+853,987
| New | +$48.4M | 0.26% | 85 |
|
|
2020
Q4 | – | Sell |
-1,256
| Closed | -$112K | – | 1709 |
|
|
2020
Q3 | $112K | Buy |
1,256
+83
| +7% | +$8.01K | ﹤0.01% | 1143 |
|
|
2020
Q2 | $121K | Buy |
1,173
+230
| +24% | +$22.2K | ﹤0.01% | 1117 |
|
|
2020
Q1 | $82K | Hold |
943
| – | – | ﹤0.01% | 1502 |
|
|
2019
Q4 | $82K | Sell |
943
-279
| -23% | -$23.8K | ﹤0.01% | 1502 |
|
|
2019
Q3 | $90K | Hold |
1,222
| – | – | ﹤0.01% | 1442 |
|
|
2019
Q2 | $103K | Buy |
1,222
+170
| +16% | +$13.6K | ﹤0.01% | 1385 |
|
|
2019
Q1 | $89K | Buy |
1,052
+393
| +60% | +$32K | ﹤0.01% | 1450 |
|
|
2018
Q4 | $41K | Buy |
+659
| New | +$42.8K | ﹤0.01% | 1676 |
|
|
2018
Q3 | – | Sell |
-501
| Closed | -$34K | – | 1628 |
|
|
2018
Q2 | $34K | Buy |
501
+24
| +5% | +$1.64K | ﹤0.01% | 1563 |
|
|
2018
Q1 | $45K | Hold |
477
| – | – | ﹤0.01% | 1673 |
|
|
2017
Q4 | $45K | Sell |
477
-210
| -31% | -$21.9K | ﹤0.01% | 1673 |
|
|
2017
Q3 | $80K | Buy |
687
+17
| +3% | +$2.15K | ﹤0.01% | 1483 |
|
|
2017
Q2 | $89K | Hold |
670
| – | – | ﹤0.01% | 1417 |
|
|
2017
Q1 | $89K | Buy |
670
+170
| +34% | +$21.6K | ﹤0.01% | 1417 |
|
|
2016
Q4 | $50K | Buy |
500
+63
| +14% | +$6.15K | ﹤0.01% | 1611 |
|
|
2016
Q3 | $41K | Sell |
437
-40
| -8% | -$3.37K | ﹤0.01% | 1678 |
|
|
2016
Q2 | $38K | Buy |
477
+250
| +110% | +$19.4K | ﹤0.01% | 1667 |
|
|
2016
Q1 | $16K | Hold |
227
| – | – | ﹤0.01% | 1881 |
|
|
2015
Q4 | $24K | Hold |
227
| – | – | ﹤0.01% | 1802 |
|
|
2015
Q3 | $25K | Buy |
+227
| New | +$25.5K | ﹤0.01% | 1822 |
|
|
2015
Q2 | – | Sell |
-600
| Closed | -$54K | – | 2728 |
|
|
2015
Q1 | $54K | Hold |
600
| – | – | ﹤0.01% | 1652 |
|
|
2014
Q4 | $43K | Buy |
+600
| New | +$39.2K | ﹤0.01% | 1797 |
|
|
2014
Q2 | – | Sell |
-80
| Closed | -$4K | – | 2359 |
|
|
2014
Q1 | $4K | Buy |
+80
| New | +$4.96K | ﹤0.01% | 2193 |
|
Other funds holding INCY
BBA
Glenmede Trust's INCY Position: Q2 2026 in Review
Glenmede Trust increased its Incyte (INCY) stake by 3% in Q2 2026, buying an estimated $1.54M and bringing the position to 538,822 shares worth $61.1M. The position accounts for 0.27% of the portfolio, ranked #79.
Glenmede Trust first reported a position in INCY in Q1 2014 and has held it in 30 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.
- Glenmede Trust held 538,822 shares of Incyte worth $61.1M as of Q2 2026.
- Glenmede Trust bought 15,531 Incyte shares in Q2 2026, an estimated $1.54M.
- Incyte made up 0.27% of Glenmede Trust's portfolio in Q2 2026, its #79 holding.
- Glenmede Trust first reported a position in Incyte in Q1 2014 and has held it in 30 quarters since.
- 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.